Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)1A receptors

被引:41
作者
Cussac, D [1 ]
Duqueyroix, D [1 ]
Newman-Tancredi, A [1 ]
Millan, MJ [1 ]
机构
[1] Inst Rech Servier, Ctr Rech Croissy, Dept Psychopharmacol, F-78290 Croissy Sur Seine, France
关键词
antipsychotic; schizophrenia; 5-HT1A; mitogen-activated protein kinase; clozapine; G(i)-protein;
D O I
10.1007/s00213-002-1043-0
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Rationale: There is evidence that serotonergic mechanisms contribute to the functional profiles of antipsychotic drugs, several of which display affinity for human (h)5-HT1A receptors. Objective: Here, we compared the interaction of several antipsychotic agents at h5-HT1A receptors employing mitogen-activated protein kinase (MAPK), an intracellular marker. Methods: The influence of antipsychotics on MAPK phosphorylation was quantified in Chinese hamster ovary (CHO) cells stably transfected with h5-HT1A receptors by use of a highly selective antibody. Results: The novel antipsychotic agent, S16924, concentration-dependently (pEC(50), 8.10) stimulated the phosphorylation of MAPK. Its maximal effect (96%) was similar to that of the prototypical 5-HT1A agonist, (+)8-OH-DPAT (pEC(50), 8.54) (defined as 100%). The selective 5-HT1A receptor antagonist WAY100,635, which was inactive alone, abolished stimulation of MAPK by S16924 with a pK(b) of 9.66. This stimulatory influence of S16924 on MAPK was potently mimicked by the benzoisoxazole, antipsychotic ziprasidone (pEC50, 7.25; 93%). The atypical antipsychotic clozapine also activated MAPK, albeit with lower potency and efficacy (pEC(50), 5.43 and 43%). These actions of ziprasidone and clozapine were also blocked by WAY 100,635. Evaluated at a single, high concentration, several other antipsychotics stimulated MAPK phosphorylation with variable efficacy: quetiapine (75%), ocaperidone (74%), tiospirone (57%), olanzapine (54%) and risperidone (21%). In all cases, their actions were abolished by WAY100,635. In contrast, haloperidol, thioridazine and sertindole did not stimulate MAPK. Conclusions: Antipsychotics display contrasting efficacies in modulating MAPK phosphorylation at h5-HT1A receptors, ranging from high (e.g. 516924 and ziprasidone), via intermediate (e.g. clozapine) to low (e.g. haloperidol). Differential modulation of 5-HT1A receptor-coupled MAPK may contribute to their contrasting functional profiles.
引用
收藏
页码:168 / 177
页数:10
相关论文
共 83 条
[1]
Agonist stimulation of the serotonin1A receptor causes suppression of anoxia-induced apoptosis via mitogen-activated protein kinase in neuronal HN2-5 cells [J].
Adayev, T ;
El-Sherif, Y ;
Barua, M ;
Penington, NJ ;
Banerjee, P .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (04) :1489-1496
[2]
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions.: I.: Neurochemical effects [J].
Akunne, HC ;
Zoski, KT ;
Davis, MD ;
Cooke, LW ;
Meltzer, LT ;
Whetzel, SZ ;
Shih, YH ;
Wustrow, DJ ;
Wise, LD ;
MacKenzie, RG ;
Georgic, LM ;
Heffner, TG ;
Pugsley, TA .
NEUROPHARMACOLOGY, 2000, 39 (07) :1197-1210
[3]
5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine [J].
Assie, MB ;
Cosi, C ;
Koek, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (2-3) :141-147
[4]
Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity [J].
Assié, MB ;
Cosi, C ;
Koek, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 386 (01) :97-103
[5]
Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)1B and h5-HT1D receptors [J].
Audinot, V ;
Newman-Tancredi, A ;
Cussac, D ;
Millan, MJ .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (03) :410-422
[6]
5-HT1A AGONIST AND DEXAMETHASONE REVERSAL OF PARA-CHLOROAMPHETAMINE INDUCED LOSS OF MAP-2 AND SYNAPTOPHYSIN IMMUNOREACTIVITY IN ADULT-RAT BRAIN [J].
AZMITIA, EC ;
RUBINSTEIN, VJ ;
STRAFACI, JA ;
RIOS, JC ;
WHITAKERAZMITIA, PM .
BRAIN RESEARCH, 1995, 677 (02) :181-192
[7]
BALDESSARINI RJ, 1990, PHARMACOL BASIS THER, P383
[8]
Bantick R. A., 2000, Journal of Psychopharmacology, V14, pA57
[9]
A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[10]
5-HT1A receptors are not involved in clozapine's lack of cataleptogenic potential [J].
Bartoszyk, GD ;
Roos, C ;
Ziegler, H .
NEUROPHARMACOLOGY, 1996, 35 (11) :1645-1646